Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)
Titel:
Treatment with MAPKAP2 (MK2) inhibitor and DNA methylation inhibitor, 5-aza dC, synergistically triggers apoptosis in hepatocellular carcinoma (HCC) via tristetraprolin (TTP)
Auteur:
Tran, Doan Duy Hai Koch, Alexandra Allister, Aldrige Saran, Shashank Ewald, Florian Koch, Martina Nashan, Björn Tamura, Teruko